$CBMG, $CTSH, $CMI, $HUM, $SPPI, $SAVE, $SU, $DIS

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Friday as follows:

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) was started with an Outperform rating and assigned a 26 price target at Robert W. Baird.

Cognizant Technology Solutions Corp. (NASDAQ:CTSH) was raised to Outperform from Market Perform at BMO Capital Markets. Shares trade in a 52-wk range of 59.47 – 85.10. The consensus price target is at 81.45.

Cummins Inc. (NYSE:CMI) was raised to Outperform from Neutral at Robert W. Baird. Shares trade in a 52-wk range of 124.40 – 173.50. The consensus price target is at 154.41.

Humana Inc. (NYSE:HUM) was maintained as Buy, but the target was lowered to 362 from 397 at Citigroup.

Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) was started with an Overweight rating and assigned a 19 target price at Cantor Fitz.

Spirit Airlines Inc. (NYSE:SAVE) was raised to Buy from Neutral and the target price was raised to 85 from 78 at Goldman Sachs. The consensus target price was 75.13, and the 52-wk trading range is 34.36 – 65.35.

Suncor Energy Inc. (NYSE:SU) was raised to Outperform from Neutral at Macquarie. Shares last closed at 33.19, in a 52-wk range of 25.81 – 42.55 and with a consensus price target at 42.83.

Walt Disney Co. (NYSE:DIS) was maintained as Market Perform but the price target was raised to 114 from 109 at BMO Capital Markets.

See Thursday’s analyst’s reports here.

Have a terrific weekend.

  analysts, avoid, buy, CBMG, CMI, consensus, CTSH, DIS, hold, HUM, price, save, sell, SPPI, stock, SU, target

The following two tabs change content below.

• Bio
• Latest Posts

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

• Support Your GI Tract from Top to Bottom - December 12, 2019
• The Street’s Key Stock Analysts Research Report - December 12, 2019
• Savvy Investors Seeing Gold at $2,500 oz Plus - December 11, 2019